Introduction {#sec1_1}
============

Approximately 340 new cases of renal cell cancer (RCC) are diagnosed each year in Ireland \[[@B1]\]. The most common sites of RCC metastases are the lung, lymph nodes, liver and bones \[[@B2]\]. RCC metastasising to the small bowel is considered uncommon, with duodenal involvement particularly rare. There are less than 40 cases reported in the English language literature to date. With the advent of newer treatment strategies and the resulting improved survival, the incidence of gastrointestinal metastatic disease will become more common \[[@B3]\]. We present a case of metastatic RCC to the duodenum which was seen recently at our institution. Full consent was obtained from the patient and his family following review of the manuscript and associated images.

Case Report {#sec1_2}
===========

A 68-year-old gentleman presented to the Emergency Department with a 2-day history of worsening shortness of breath, fatigue and melena. He had been diagnosed with renal cell carcinoma with metastases to the bones, liver and lymph nodes 18 months previously. He was undergoing second-line treatment with nivolumab and recent imaging had demonstrated a partial response to treatment. Of note, his medications included therapeutic anticoagulation for a previous pulmonary embolus.

Routine blood tests demonstrated a haemoglobin level of 6.5 g/dL, a considerable decline from his baseline level of 11.8 g/dL a week prior to presentation. His faecal occult blood was positive. His anticoagulation was held, and he was transfused two units of red blood cells. He proceeded to urgent oesophago-gastro duodenoscopy, which demonstrated a polypoid lesion in the second segment of the duodenum (Fig. [1](#F1){ref-type="fig"}).

Duodenal biopsies demonstrated variable mucosal and submucosal infiltration by carcinoma with an epithelioid morphology and areas of prominent cytoplasmic clearing. This was in keeping with his metastatic renal cell carcinoma (Fig. [2](#F2){ref-type="fig"}).

Due to ongoing bleeding, the decision was taken to embolise the tumour under radiological guidance. This proved successful and the patient\'s haemoglobin level stabilised. Restaging computed topography (CT) revealed the development of pulmonary metastases and rapid progression of existing sites of disease. As his performance status remained satisfactory, his systemic treatment was changed to a third-generation tyrosine kinase inhibitor axitinib.

Discussion {#sec1_3}
==========

A recent cohort study of over 3,000 patients described the prevalence of symptomatic small intestinal metastases from RCC as 0.71%, although post mortem studies have found a higher incidence at 2% \[[@B4], [@B5]\]. The ileum is the most common site of disease, with duodenal metastases from RCC being a much rarer phenomenon \[[@B3], [@B5]\].

Metastases can be a result of direct infiltration, lymphatic or haematogenous spread \[[@B5]\].

Owing to the vascular nature of RCC, those with duodenal metastases most commonly present with acute or chronic upper gastrointestinal bleeding. This is of particular concern given a significant number of these patients require anticoagulation for malignancy-related thromboembolic events \[[@B6]\]. Additionally, cases of obstruction, perforation, intussusception and obstructive jaundice secondary to duodenal metastases from RCC have been reported \[[@B7]\]. On direct visualisation by endoscopy lesions are mostly solitary, polypoid or ulcerated submucosal masses \[[@B4]\].

There is no standard management for duodenal metastases with an individualised approach recommended. In fit patients, with a solitary duodenal RCC metastasis, complete surgical resection should be considered. In those with widespread disease, palliative approaches include palliative surgery, embolisation, radiotherapy or systemic treatment \[[@B8]\].

Conclusion {#sec1_4}
==========

Metastatic spread to the duodenum by RCC should be considered in patients with RCC presenting with signs or symptoms of upper gastrointestinal bleeding, iron deficiency anaemia or unexplained gastrointestinal symptoms.
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